4.7 Article

Protective effect of ginsenoside Rh2 against Toxoplasma gondii infection-induced neuronal injury through binding TgCDPK1 and NLRP3 to inhibit microglial NLRP3 inflammasome signaling pathway

Related references

Note: Only part of the references are listed.
Article Parasitology

Toxoplasma gondii activates NLRP12 inflammasome pathway in the BALB/c murine model

Saba Rajabi et al.

Summary: The study investigated the role of NLRP12 in murine toxoplasmosis, finding that NLRP12 regulation is crucial for modulating the immunological response during infection. The gene expression levels showed significant changes during infection, highlighting the importance of NLRP12 in host-T. gondii interaction.

ACTA TROPICA (2022)

Article Pharmacology & Pharmacy

Convallatoxin inhibits IL-1β production by suppressing zinc finger protein 91 (ZFP91)-mediated pro-IL-1β ubiquitination and caspase-8 inflammasome activity

Yue Xing et al.

Summary: The study reveals that convallatoxin inhibits IL-1 beta production by down-regulating ZFP91, thus preventing inappropriate inflammatory responses and maintaining immune homeostasis. This finding provides new insights for the development of convallatoxin as a novel anti-inflammatory drug targeting ZFP91.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

Article Immunology

Deficiency in indoleamine-2, 3-dioxygenase induces upregulation of guanylate binding protein 1 and inducible nitric oxide synthase expression in the brain during cerebral infection with Toxoplasma gondii in genetically resistant BALB/c mice but not in genetically susceptible C57BL/6 mice

Namrata Anand et al.

Summary: The study examined the role of IDOL in controlling cerebral Toxoplasma gondii infection in genetically resistant and susceptible strains of mice. The results showed that IDO1 deficiency in genetically resistant mice was compensated by the upregulated expression of Gbp1 and NOS2 to control the growth of cerebral tachyzoites. In contrast, IDO1 did not significantly contribute to controlling cerebral tachyzoite growth in genetically susceptible mice due to its suppressed expression in infected cells.

MICROBES AND INFECTION (2022)

Article Plant Sciences

Ginsenoside Rh2 reduces depression in offspring of mice with maternal toxoplasma infection during pregnancy by inhibiting microglial activation via the HMGB1/TLR4/NF-κB signaling pathway

Xiang Xu et al.

Summary: This study demonstrated that GRh2 ameliorated depression-like behavior in mouse offspring of maternal T. gondii infection during pregnancy by attenuating excessive microglial activation and neuroinflammation through the HMGB1/TLR4/NF-kappa B signaling pathway. It suggests that GRh2 could be considered a potential therapy in preventing and treating psychiatric disorders in the offspring of mothers with prenatal exposure to T. gondii infection.

JOURNAL OF GINSENG RESEARCH (2022)

Article Chemistry, Medicinal

Protective effect of ginsenoside Rh2 on scopolamine-induced memory deficits through regulation of cholinergic transmission, oxidative stress and theERK-CREB-BDNFsignaling pathway

Jingwei Lv et al.

Summary: The study demonstrated that Rh2 treatment effectively improved memory deficits induced by Scop in mice by modulating the cholinergic system, inhibiting oxidative stress, and activating the ERK-CREB-BDNF signaling pathway. These findings suggest that Rh2 may be a promising candidate compound for treating Alzheimer's disease.

PHYTOTHERAPY RESEARCH (2021)

Article Pharmacology & Pharmacy

Resveratrol modulates Toxoplasma gondii infection induced liver injury by intervening in the HMGB1/TLR4/NF-κB signaling pathway

Jing-Mei Lu et al.

Summary: The study demonstrates that resveratrol can protect liver injury induced by T. gondii infection by intervening in the HMGB1/TLR4/NF-kappa B signaling pathway.

EUROPEAN JOURNAL OF PHARMACOLOGY (2021)

Review Cardiac & Cardiovascular Systems

Toxoplasmosis and the Heart

Zier Zhou et al.

Summary: Toxoplasmosis, caused by a parasite, is common in tropical regions and often shows minimal symptoms, though immunocompromised patients have a poor prognosis. Cardiovascular manifestations are rare and mainly involve myocarditis, presenting diagnostic challenges. This systematic review aims to summarize available information on cardiac implications of toxoplasmosis.

CURRENT PROBLEMS IN CARDIOLOGY (2021)

Article Immunology

New role of sertraline against Toxoplasma gondii-induced depression-like behaviours in mice

Hui-Wen Lan et al.

Summary: This study investigated the effects of sertraline (SERT) on T. gondii-induced depression-like behaviors, revealing that SERT ameliorated depression-like behaviors in T. gondii-infected mice by inhibiting parasite proliferation and regulating microglial activation. The study also identified the underlying molecular mechanisms involved in the protective role of SERT against T. gondii-induced depression-like behaviors, shedding light on potential therapeutic strategies.

PARASITE IMMUNOLOGY (2021)

Review Pharmacology & Pharmacy

Therapeutic potential of the target on NLRP3 inflammasome in multiple sclerosis

Shuai Shao et al.

Summary: Inflammasomes are multi-protein complexes that regulate the maturation and secretion of IL-1 beta and IL-18 in response to PAMPs or DAMPs in host cells. The NLRP3 inflammasome is well-understood in molecular mechanisms, serving as a promising therapeutic target in immune-related disorders such as multiple sclerosis (MS). Investigation of NLRP3 activation mechanisms in MS and experimental models may lead to new therapeutic strategies for the disease.

PHARMACOLOGY & THERAPEUTICS (2021)

Article Parasitology

Expression profiles of NOD-like receptors and regulation of NLRP3 inflammasome activation in Toxoplasma gondii-infected human small intestinal epithelial cells

Jia-Qi Chu et al.

Summary: This study revealed the expression profiles of NLRs and uncovered the underlying mechanisms of NLRP3 inflammasome activation in T. gondii-infected FHs 74 Int cells. These findings may contribute to understanding the mucosal and innate immune responses induced by NLRs and inflammasomes during T. gondii infection in FHs 74 Int cells.

PARASITES & VECTORS (2021)

Article Plant Sciences

Salvianolic Acids for Injection alleviates cerebral ischemia/reperfusion injury by switching M1/M2 phenotypes and inhibiting NLRP3 inflammasome/pyroptosis axis in microglia in vivo and in vitro

Dai-Chao Ma et al.

Summary: SAFI may exert neuroprotective effects by reducing neuronal apoptosis, shifting microglial phenotype from M1 to M2, and inhibiting NLRP3 inflammasome/pyroptosis axis in microglia.

JOURNAL OF ETHNOPHARMACOLOGY (2021)

Article Neurosciences

Subcellular localization of neuronal nuclei (NeuN) antigen in size and calcitonin gene-related peptide (CGRP) populations of dorsal root ganglion (DRG) neurons during acute peripheral inflammation

Michael B. Anderson et al.

Summary: The study focused on the expression pattern of NeuN immunoreactivity in small CGRP positive DRG neurons during inflammation, indicating a potential role for NeuN in a subset of nociceptive neurons.

NEUROSCIENCE LETTERS (2021)

Article Biochemistry & Molecular Biology

Ginsenoside Rg1 attenuates cardiomyocyte apoptosis and inflammation via the TLR4/NF-kB/NLRP3 pathway

Man Luo et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2020)

Article Immunology

Infection by the Protozoan Parasite Toxoplasma gondii Inhibits Host MNK1/2-eIF4E Axis to Promote Its Survival

Louis-Philippe Leroux et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)

Review Immunology

Advances and Challenges in Understanding Cerebral Toxoplasmosis

Dirk Schlueter et al.

FRONTIERS IN IMMUNOLOGY (2019)

Editorial Material Biochemistry & Molecular Biology

Toxoplasma gondii

Joshua A. Kochanowsky et al.

CURRENT BIOLOGY (2018)

Article Clinical Neurology

NLRP3 Inflammasome Activation Leads to Epileptic Neuronal Apoptosis

Kai Shen et al.

CURRENT NEUROVASCULAR RESEARCH (2018)

Review Neurosciences

NLRP3 Inflammasome in Neurological Diseases, from Functions to Therapies

Limin Song et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2017)

Review Pharmacology & Pharmacy

Adverse Event Profile of Pyrimethamine-Based Therapy in Toxoplasmosis: A Systematic Review

Ruben R. Ben-Harari et al.

DRUGS IN R&D (2017)

Article Multidisciplinary Sciences

Mitochondrial behaviour throughout the lytic cycle of Toxoplasma gondii

Jana Ovciarikova et al.

SCIENTIFIC REPORTS (2017)

Article Immunology

HSP60 plays a regulatory role in IL-1β-induced microglial inflammation via TLR4-p38 MAPK axis

Shalini Swaroop et al.

JOURNAL OF NEUROINFLAMMATION (2016)

Review Microbiology

Lytic Cycle of Toxoplasma gondii: 15 Years Later

Ira J. Blader et al.

ANNUAL REVIEW OF MICROBIOLOGY, VOL 69 (2015)

Review Parasitology

Research progress on surface antigen 1 (SAG1) of Toxoplasma gondii

Yanhua Wang et al.

PARASITES & VECTORS (2014)

Article Parasitology

Activated microglia contribute to neuronal apoptosis in Toxoplasmic encephalitis

Yi-hua Zhang et al.

PARASITES & VECTORS (2014)

Article Biology

Identification of BACE1 inhibitors from Panax ginseng saponins-An Insilco approach

Karpagam Veerappan et al.

COMPUTERS IN BIOLOGY AND MEDICINE (2013)

Review Microbiology

Epidemiology of and Diagnostic Strategies for Toxoplasmosis

Florence Robert-Gangneux et al.

CLINICAL MICROBIOLOGY REVIEWS (2012)

Review Biochemistry & Molecular Biology

The Inflammasomes

Kate Schroder et al.

Review Biochemistry & Molecular Biology

Mechanisms Underlying Inflammation in Neurodegeneration

Christopher K. Glass et al.

Article Food Science & Technology

Pharmacokinetic characterization of ginsenoside Rh2, an anticancer nutrient from ginseng, in rats and dogs

Yi Gu et al.

FOOD AND CHEMICAL TOXICOLOGY (2009)

Article Chemistry, Multidisciplinary

AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility

Garrett M. Morris et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)

Review Plant Sciences

Progress in understanding of ginsenoside biosynthesis

Y. Liang et al.

PLANT BIOLOGY (2008)

Review Medicine, General & Internal

Toxoplasmosis

JG Montoya et al.

LANCET (2004)